Golden has been acquired by ComplyAdvantage.Read about it here ⟶

QurCan Therapeutics Inc.

QurCan Therapeutics Inc.

Developer of a nanotechnology-based drug delivery platform intended to provide precision medicine for solid-tumor cancer therapy. The company's platform TERP overcomes the poor drug release and liver accumulation of lipid nanoparticles and efficiently delivers drugs, antibodies and RNA to hard-to-reach tumors, including the brain.

Overview Structured Data Issues Contributors Activity

Is a

Company attributes

Industry

0

0

Pharmaceutical industry

Location

0

0

0

Cambridge, Massachusetts

0

CEO

0

Founder

0

0

Pitchbook URL

pitchbook.com/profiles...234578-89

Legal Name

QURCAN THERAPEUTICS INC.0

Full Address

Jlabs Toronto, 661 University Ave., Toronto, ON, Canada. M5G 1M1.0

LabCentral, 700 Main St, Cambridge, MA 02139, United States.0

Investors

Ontario Brain Institute

0

Facit (Fight Against Cancer Innovation Trust)

0

Creative Destruction Lab

0

Ontario Centres of Excellence

Founded Date

2018

0

Total Funding Amount (USD)

3,000,000

Latest Funding Round Date

March 17, 2021

Competitors

Braizon Therapeutics

0

Board of Directors

0

0

Also Known As

Nanology Labs0

Latest Funding Type

Other attributes

Latest Funding Round Amount (USD)

3,000,000

Public/Private

Private0

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like QurCan Therapeutics Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool